---
figid: PMC10670038__cancers-15-05347-g006
figtitle: Mechanism of the synergistic effect of CuET and GSKJ4 in the treatment of
  ESCC
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10670038
filename: PMC10670038__cancers-15-05347-g006.jpg
figlink: /pmc/articles/PMC10670038/figure/F6
number: F6
caption: Schematic diagram of the mechanism of the synergistic effect of CuET and
  GSKJ4 in the treatment of ESCC. The red cross characterizes the inhibition of the
  signaling pathway
papertitle: Targeting Esophageal Squamous Cell Carcinoma by Combining Copper Ionophore
  Disulfiram and JMJD3/UTX Inhibitor GSK J4
reftext: Canlin Yang, et al. Cancers (Basel). 2023 Nov;15(22).
year: '2023'
doi: 10.3390/cancers15225347
journal_title: Cancers
journal_nlm_ta: Cancers (Basel)
publisher_name: MDPI
keywords: disulfiram | JMJD3 | UTX | UPR | ESCC
automl_pathway: 0.9408463
figid_alias: PMC10670038__F6
figtype: Figure
redirect_from: /figures/PMC10670038__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10670038__cancers-15-05347-g006.html
  '@type': Dataset
  description: Schematic diagram of the mechanism of the synergistic effect of CuET
    and GSKJ4 in the treatment of ESCC. The red cross characterizes the inhibition
    of the signaling pathway
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - UFD1
  - EIF4G2
  - PSMD2
  - VCP
  - CFDP1
  - GEMIN4
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - NPLOC4
  - proteins
  - Action
---
